Elu­ci­da On­col­o­gy, seek­ing foothold in AD­Cs, shut­ters due to 'lack of fund­ing'

Elu­ci­da On­col­o­gy, a clin­i­cal-stage biotech led by for­mer Pfiz­er ex­ec­u­tive Geno Ger­mano, has shut down, End­points News has learned.

The New Jer­sey start­up was try­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER